| Literature DB >> 29556893 |
Hiroki Nishiwaki1,2, Takeshi Hasegawa3,4,5, Megumi Shinji6, Fujio Matsuo6, Tsuyoshi Watanabe7, Hirofumi Makino8, Fumihiko Koiwa1, Akira Hishida9.
Abstract
BACKGROUND: The practice patterns of exercise restrictions for patients with chronic kidney disease have not been adequately evaluated yet; thus, we examined them using a cross-sectional design and explored the factors related with those restrictions.Entities:
Keywords: Adult; Chronic kidney disease; Exercise restrictions; Physical activities; Practice pattern
Mesh:
Year: 2018 PMID: 29556893 PMCID: PMC6154124 DOI: 10.1007/s10157-018-1562-6
Source DB: PubMed Journal: Clin Exp Nephrol ISSN: 1342-1751 Impact factor: 2.801
Patient characteristics by exercise restrictions
| Exercise restrictions | All | ||
|---|---|---|---|
| No | Yes | ||
| Age, years (SD) | 60.6 (11.4) | 57.6 (12.8) | 60.3 (11.6) |
| Gender, female, % | 37.6% | 39.5% | 37.8% |
| Cause of CKD, | |||
| Diabetic nephropathy | 427 (18.5%) | 62 (24.5%) | 289 (19.1%) |
| Non-diabetic | 1885 (81.5%) | 191 (75.5%) | 2076 (80.9%) |
| Comorbidities | |||
| Cardiovascular disease, % | 12.8% | 17.4% | 13.3% |
| Stroke, % | 9.8% | 8.7% | 9.7% |
| Congestive heart failure, % | 3.4% | 6.3% | 3.7% |
| Smoking | |||
| Active smoker | 17.1% | 15.1% | 16.9% |
| Ex-smoker | 27.9% | 27.8% | 27.9% |
| Non-smoker | 55.0% | 57.1% | 55.2% |
| Alcohol use | 39.8% | 34.3% | 39.2% |
Exercise Restrictions: We used the information about the restriction of the physical activities offered by the physician in the questionnaire at the enrollment. The patients reported “Yes” or “No” about the restriction of the exercise in this questionnaire
SD standard deviation, CKD Chronic Kidney disease
Laboratory data by exercise restrictions
| Exercise restrictions | All | ||
|---|---|---|---|
| No | Yes | ||
| BMI (SD) | 23.5 (3.78) | 23.2 (4.1) | 23.5 (3.8) |
| Systolic blood pressure, mmHg (SD) | 132 (18) | 132 (18) | 132 (18) |
| Diastolic blood pressure, mmHg (SD) | 77 (12) | 76 (12) | 77 (12) |
| Uncontrollable hypertension, | 32 (1.4%) | 1 (0.4%) | 33 (1.3%) |
| Hemoglobin, g/dl (SD) | 12.1 (1.9) | 11.7 (1.7) | 12.1 (1.9) |
| Hematocrit, % (SD) | 36.4 (5.3) | 35.1 (4.9) | 36.2 (5.3) |
| Serum creatinine, mg/dl (SD) | 2.1 (1.1) | 2.3 (1.2) | 2.1 (1.1) |
| eGFR, ml/min/1.73 m2 (SD) | 29.1 (12.4) | 27.3 (11.8) | 28.9 (12.3) |
| CKD stage, | |||
| 3a | 231 (10.6%) | 19 (8.3%) | 250 (10.4%) |
| 3b | 765 (35.0%) | 69 (30.0%) | 834 (34.5%) |
| 4 | 837 (38.3%) | 102 (44.3%) | 939 (38.9%) |
| 5 | 339 (15.5%) | 40 (17.4%) | 379 (15.7%) |
| Urine albumin, mg/g Cr (SD) | 941.2 (1252.5) | 1113.1 (1515.1) | 957.6 (1280.3) |
Uncontrollable hypertension was defined as more than 180 mmHg in the systolic blood pressure and/or 110 mmHg in diastolic pressure
BMI body mass index, SD standard deviation, eGFR estimated glomerular filtration rate, CKD chronic kidney disease
Fig. 1Rate of the exercise restrictions by the facilities. Facility A–E: 1st tertile, F–K: 2nd tertile, L–Q: 3rd tertile
Patient’s characteristics by tertile of proportion of physician’s direction of exercise restriction
| Tertile of proportion of exercise restriction each facilities | ||||
|---|---|---|---|---|
| 1st tertile | 2nd tertile | 3rd tertile | ||
| Age | 61.2 (10.7) | 59.9 (12.0) | 59.9 (11.7) | 0.44* |
| Gender (female) | 284 (40.8%) | 309 (35.1%) | 377 (38.1%) | 0.62 |
| Diabetic nephropathy | 123 (17.7%) | 157 (17.8%) | 209 (21.1%) | 0.11 |
| CVD | 118 (17.0%) | 99 (11.3%) | 123 (12.4%) | < 0.01*☨ |
| Stroke | 61 (8.8%) | 82 (9.3%) | 105 (10.6%) | 0.41 |
| CHF | 24.0 (3.4%) | 25 (2.8%) | 45 (4.6%) | 0.14 |
| BMI | 23.5 (3.78) | 23.25 (3.74) | 23.66 (3.89) | 0.08* |
| Systolic blood pressure | 134.3 (19.1) | 127.9 (17.8) | 133.4 (17.8) | < 0.01*☨ |
| Uncontrollable hypertension | 13 (1.9%) | 8 (0.9%) | 12 (1.2%) | 0.21 |
| eGFR | 8 (12.27) | 29.38 (12.35) | 29.09 (12.34) | 0.10 |
| CKD stage | 0.54 | |||
| 3a | 70 (10.3%) | 88 (10.4%) | 92 (10.4%) | |
| 3b | 219 (32.2%) | 297 (35.1%) | 318 (35.9%) | |
| 4 | 269.0 (39.5%) | 337 (39.8%) | 333 (37.6%) | |
| 5 | 121 (17.8%) | 119 (14.0%) | 139 (15.7%) | |
| Albuminuria | 834 (1114.29) | 951.52 (1322.45) | 1059.05 (1350.34) | < 0.01*☨ |
| Total cholesterol | 188.1 (37.8) | 193.9 (47.2) | 197.9 (41.2) | < 0.01*☨ |
Uncontrollable hypertension was defined as more than 180 mmHg in the systolic blood pressure and/or 110 mmHg in diastolic pressure
BMI body mass index, CVD cardiovascular disease, CHF congestive heart failure, eGFR estimated glomerular filtration rate, CKD chronic kidney disease
*< 0.05, Comparisons were assessed using the chi-squire test, except for ☨ using ANOVA
Logistic Analysis for the Exercise Restrictions and Data Missing
| Univariate | Multivariate | Data missing ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Not stratified | Stratified by the facilities | Not stratified | Stratified by the facilities | |||||||
| OR | OR | OR | OR | |||||||
| Ratio | 95% CI | Ratio | 95% CI | Ratio | 95% CI | Ratio | 95% CI | |||
| Agea | 0.81* | 0.73–0.90 | 0.81* | 0.73–0.90 | 0.75* | 0.66–0.86 | 0.75* | 0.66–0.86 | 0 | 0.0 |
| Gender | 0.92 | 0.71–1.20 | 0.91 | 0.69–1.19 | 0.84 | 0.62–1.14 | 0.83 | 0.61–1.13 | 0 | 0.0 |
| Diabetic nephropathy | 1.43* | 1.06–1.94 | 1.45* | 1.06–1.99 | 1.45 | 1.00–2.11 | 1.44 | 0.98–2.12 | 0 | 0.0 |
| CVD | 1.43* | 1.01–2.03 | 1.58* | 1.10–2.25 | 1.66* | 1.11–2.50 | 1.85* | 1.22–2.82 | 0 | 0.0 |
| Stroke | 0.88 | 0.56–1.39 | 0.9 | 0.54–1.37 | 0.94 | 0.56–1.59 | 0.92 | 0.54–1.57 | 0 | 0.0 |
| CHF | 1.93* | 1.11–3.37 | 1.83* | 1.04–3.23 | 2.21* | 1.23–3.97 | 2.07* | 1.14–3.78 | 0 | 0.0 |
| BMI | 0.98 | 0.94–1.01 | 0.98 | 0.94–1.01 | 0.97 | 0.93–1.01 | 0.97 | 0.93–1.01 | 239 | 9.3 |
| Systolic blood pressure | 1.00 | 0.93–1.07 | 1.00 | 0.92–1.07 | 1.00 | 0.93–1.11 | 1.02 | 0.94–1.12 | 25 | 1.0 |
| Uncontrollable hypertension | 0.28 | 0.04–2.06 | 0.30 | 0.04–2.22 | 60 | 2.3 | ||||
| eGFRa | 0.89* | 0.79–0.99 | 0.88* | 0.78–0.98 | 0.87* | 0.77–0.99 | 0.86* | 0.75–0.97 | 151 | 5.9 |
| CKD stage | ||||||||||
| 3a | Reference | Reference | ||||||||
| 3b | 1.10 | 0.65–1.86 | 1.09 | 0.64–1.86 | ||||||
| 4 | 1.48 | 0.89–2.47 | 1.52 | 0.91–2.54 | ||||||
| 5 | 1.43 | 0.81–2.54 | 1.48 | 0.83–2.63 | ||||||
| Urine albuminb | 1.05 | 1.00–1.10 | 1.04 | 0.99–1.09 | 1.00 | 0.94–1.06 | 0.98 | 0.93–1.05 | 187 | 7.3 |
“Stratified by the facilities” is the logistic regression analysis stratified by the facilities
OR odds ratio, CKD chronic kidney disease, CVD cardiovascular disease, CHF congestive heart failure, BMI body mass index, eGFR estimated glomerular filtration rate
*p < 0.05
a Unit by 10
b Unit by 500